Início › Doenças Autoimunes › Illinois
Ensaios clínicos de Doenças Autoimunes em Illinois
14 estudos para Doenças Autoimunes estão buscando participantes em locais em Illinois.
Cidades em Illinois
Texto oficial do estudo (Inglês)
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
- Willow Rheumatology Wellness, Willowbrook
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07621809RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- Ann & Robert H. Lurie Children's Hospital of Chicago - Accepting Young Adult and Juvenile Patients, Chicago
- Northwestern Memorial Hospital - Accepting Adult Patients, Chicago
- The University of Chicago Medical Center - Accepting Adult and Juvenile Patients, Chicago
RecrutandoFase 2/3
Idades de 6 a 75 · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT06154252Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
- University of Chicago, Department of Medicine: Rheumatology, Chicago
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT07103746A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
- University of Chicago, Chicago
RecrutandoFase 2
Idades de 16 a 70 · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT07328581A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- The University of Chicago Medical Center, Chicago
RecrutandoFase 1
Idades de 18 a 74 · Todos os sexos · Atualizado em 10 de set. de 2026 · NCT07085104RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- Northwestern Memorial Hospital, Chicago
- The University of Chicago Medical Center, Chicago
RecrutandoFase 1/2
Idades de 18 a 65 · Todos os sexos · Atualizado em 26 de ago. de 2026 · NCT06121297A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
- University of Illinois Hospital & Health Sciences System, Chicago
RecrutandoFase 1/2
Idades de 35 a 70 · Todos os sexos · Atualizado em 21 de ago. de 2026 · NCT06575426RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
- Northwestern Memorial Hospital, Chicago
- The University of Chicago Medical Center, Chicago
RecrutandoFase 2/3
Idades de 18 a 75 · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT06328777RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
- Northwestern Memorial Hospital, Chicago
RecrutandoFase 1/2
Idades de 18 a 70 · Todos os sexos · Atualizado em 13 de ago. de 2026 · NCT06359041Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1054, Schaumburg
RecrutandoFase 3
Idades de 18 a 80 · Todos os sexos · Atualizado em 30 de jul. de 2026 · NCT07039916A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Northwestern Memorial Hospital, Chicago
- Rush University Medical Center, Chicago
- University of Illinois at Chicago, Chicago
- e mais 3
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 6 de jul. de 2026 · NCT01351545Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis
- Northwestern University, Chicago
RecrutandoFase 1
Idades de 18 a 70 · Todos os sexos · Atualizado em 30 de jun. de 2026 · NCT06201416A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
- Northwestern University, Chicago
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 29 de mai. de 2026 · NCT04422912The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
- University of Chicago Medical Center, Chicago
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades 18 e acima · Todos os sexos · Atualizado em 4 de mar. de 2026 · NCT01280825Fonte: ClinicalTrials.gov, dados obtidos em 2 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.